Immunocore Holdings plc - ADR (IMCR)

Historical Holders from Q1 2021 to Q3 2025

Symbol
IMCR on Nasdaq
CUSIP
45258D105
Type / Class
Equity / ADR
Shares outstanding
50.2M
All holders as of June 30, 2025
Q2 2025
Total 13F shares, excl. options
47.8M
Holdings value
$1.5B
% of all portfolios
0.003%
Grand Portfolio weight change
+0%
Number of holders
132
Number of buys
76
Number of sells
-52
Average Value change %
+0%
Average buys %
+0.001%
Average sells %
-0.001%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Immunocore Holdings plc - ADR (IMCR)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
T. Rowe Price Investment Management, Inc. 14.1% $182M 7.05M T. Rowe Price Investment Management, Inc. Mar 31, 2025
WELLINGTON MANAGEMENT GROUP LLP 10.2% +12.2% $153M $18.4M 5.13M +13.7% Wellington Management Group LLP Jul 31, 2025
Jallal Bahija 8.2% $116M 4.49M Jallal Bahija Dec 31, 2024
PRIMECAP MANAGEMENT CO/CA/ 7.51% +43.6% $122M $35.6M 3.77M +41.4% PRIMECAP MANAGEMENT CO/CA/ Jun 30, 2025

Institutional Holders of Immunocore Holdings plc - ADR (IMCR)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 914 $33.2K +$11.3K $36.33 1
2025 Q2 47.8M $1.5B +$18M $31.38 132
2025 Q1 47.3M $1.4B +$60.3M $29.67 115
2024 Q4 45.4M $1.34B -$4.7M $29.50 113
2024 Q3 45.3M $1.41B +$61.2M $31.13 129
2024 Q2 43M $1.46B -$100M $33.89 135
2024 Q1 41.2M $2.68B +$247M $65.00 153
2023 Q4 168K $11.5M +$5.43M $68.32 3
2023 Q3 36.9M $1.92B +$85.3M $51.90 123
2023 Q2 35.3M $2.11B +$164M $59.96 116
2023 Q1 32.7M $1.61B +$119M $49.44 107
2022 Q4 30.2M $1.73B +$252M $57.07 100
2022 Q3 26.3M $1.24B +$213M $46.94 80
2022 Q2 21M $784M +$55.8M $37.31 64
2022 Q1 19.7M $590M +$57.7M $29.90 57
2021 Q4 17.1M $587M +$22M $34.24 45
2021 Q3 16.7M $617M +$83.1M $37.07 46
2021 Q2 13.8M $538M +$9.42M $39.05 42
2021 Q1 14.1M $598M +$598M $42.57 41